F. Shepherd - Concepedia

Author

F. Shepherd

Princess Margaret Cancer Centre

Also Known As

F A Shepherd, F Shepherd, F. A. Shepherd, F. Shepherd, F.A. Shepherd, FA Shepherd, Shepherd, FA

Publications

2.4K

Citations

H-Index

Concepts

All Affiliations

Princess Margaret Cancer Centre Ottawa Regional Cancer Foundation Ontario Institute for Cancer Research Toronto General Hospital University of Toronto

About

F. Shepherd is an author at Princess Margaret Cancer Centre specializing in cancer therapeutics, lung cancer, and medicine.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	12	14	842
2	Health Sciences	6	6	148
3	Pathology	5	5	534
4	Gender Studies	1	1	46
5	Obstetrics	1	1	46

F. Shepherd

Publications

2.3K

Citations

H-Index

Page 1

	Year	Citations
Osimertinib or platinum–pemetrexed in EGFR T790M–positive lung cancer Tony Mok, Yi‐Long Wu, M. Ahn, QUT ePrints (Queensland University of Technology)	2017	474
Randomized phase III trial of liposomal daunorubicin versus doxorubicin, bleomycin, and vincristine in AIDS-related Kaposi's sarcoma. Parkash S. Gill, J Wernz, David T. Scadden, Journal of Clinical Oncology	1996	437
Diffuse malignant mesothelioma of the pleura in Ontario and Quebec: a retrospective study of 332 patients. Pierre Ruffiè, R. Feld, Salomon Minkin, Journal of Clinical Oncology Retrospective StudyAppropriate Stratification VariablesTumoral PathologyWeight LossMedicine	1989	371
Second Primary Cancers Related to Smoking and Treatment of Small-Cell Lung Cancer Margaret A. Tucker, Nevin Murray, Edward G. Shaw, JNCI Journal of the National Cancer Institute	1997	215
Cushing's syndrome associated with ectopic corticotropin production and small-cell lung cancer. F. Shepherd, Jennifer Laskey, William K. Evans, Journal of Clinical Oncology	1992	140
Randomised, double-blind trial of carboplatin and paclitaxel with daily oral cediranib or placebo in patients with advanced non-small cell lung cancer: NCIC Clinical Trials Group study BR29 Scott A. Laurie, Benjamin Solomon, Lesley Seymour, European Journal of Cancer Daily Oral CediranibOncologyMetronomic TherapyPharmacologyClinical Trials	2013	108
The prognostic significance of pretreatment serum lactate dehydrogenase in patients with small-cell lung cancer. Uri Sagman, Ronald Feld, William K. Evans, Journal of Clinical Oncology Prognostic BiomarkersElevated LdhNormal Ldh LevelMedicineSerum Ldh	1991	85
Second primary malignancies following diagnosis of small-cell lung cancer. Uri Sagman, Michael Lishner, Ellen Maki, Journal of Clinical Oncology	1992	77
Enhancement of the Tumorigenicity of Preneoplastic Mammary Nodule Lines by Enzymatic Dissociation2 Daniel Medina, F. Shepherd, T. Gropp JNCI Journal of the National Cancer Institute	1978	53
The strength of female sex as a prognostic factor in small-cell lung cancer: a pooled analysis of chemotherapy trials from the Manchester Lung Group and Medical Research Council Clinical Trials Unit Paul Wheatley‐Price, Clement Ma, Linda Ashcroft, Annals of Oncology Manchester Lung GroupFemale SexMedicineGender StudiesEpidemiology Of Cancer	2009	46

Page 1